ARCHIVES

NeoPharm To Begin Phase III Trial For Glioblastoma

This article is from The Cancer Letter archive.

Vol. 26 No. 12 | December 26, 2003

Download PDF Visit The Full Archive

Related Articles

Drugs and Targets: EU approves Imbruvica in MCL, CLL

October 24, 2014

A tissue bank to break the bank? NCI, National Dialogue on Cancer plan expensive resource.

August 8, 2003

Firm Buys Rights To NKT Cells From Beth Israel Deaconess.

July 28, 2000

NCI Grant Funding: “Zone of Likelihood” Moves From 7th to 9th Percentile

November 30, 2012

News Analysis: IOM Report A Case Study In Communications Disaster

February 5, 1999

CCRAC Calls for New Comp Center, Community Hospital Core Grants For Control Development

August 24, 1979